Regions Financial Corp’s AbbVie ABBV Stock Holding History

Regions Financial Corp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$161M	Buy	739,038 +26,524	+4%	+$5.88M	1.04%	24
2025 Q4	$163M	Buy	712,514 +5,348	+0.8%	+$1.22M	1.04%	24
2025 Q3	$164M	Buy	707,166 +44,325	+7%	+$9.03M	1.07%	23
2025 Q2	$123M	Buy	662,841 +78,456	+13%	+$14.6M	0.85%	23
2025 Q1	$122M	Buy	584,385 +143,251	+32%	+$27.8M	0.91%	24
2024 Q4	$78.4M	Buy	441,134 +28,605	+7%	+$5.26M	0.58%	41
2024 Q3	$81.5M	Buy	412,529 +4,937	+1%	+$921K	0.59%	44
2024 Q2	$69.9M	Buy	407,592 +201,676	+98%	+$33.4M	0.53%	48
2024 Q1	$37.5M	Buy	205,916 +7,371	+4%	+$1.27M	0.28%	92
2023 Q4	$30.8M	Sell	198,545 -6,661	-3%	-$971K	0.25%	99
2023 Q3	$30.6M	Sell	205,206 -5,571	-3%	-$818K	0.28%	93
2023 Q2	$28.4M	Buy	210,777 +9,070	+4%	+$1.33M	0.25%	102
2023 Q1	$32.1M	Sell	201,707 -25,955	-11%	-$3.97M	0.29%	93
2022 Q4	$36.8M	Sell	227,662 -9,627	-4%	-$1.48M	0.34%	84
2022 Q3	$31.8M	Sell	237,289 -18,952	-7%	-$2.72M	0.32%	88
2022 Q2	$39.2M	Sell	256,241 -24,951	-9%	-$3.81M	0.37%	81
2022 Q1	$45.6M	Sell	281,192 -86,403	-24%	-$12.6M	0.37%	80
2021 Q4	$49.8M	Sell	367,595 -273,864	-43%	-$32.4M	0.39%	76
2021 Q3	$69.2M	Sell	641,459 -17,522	-3%	-$2M	0.6%	51
2021 Q2	$74.2M	Sell	658,981 -5,688	-0.9%	-$641K	0.64%	47
2021 Q1	$71.9M	Buy	664,669 +5,859	+0.9%	+$627K	0.65%	47
2020 Q4	$70.6M	Buy	658,810 +1,964	+0.3%	+$189K	0.68%	42
2020 Q3	$57.5M	Buy	656,846 +12,176	+2%	+$1.15M	0.63%	45
2020 Q2	$63.3M	Buy	644,670 +34,189	+6%	+$3.01M	0.74%	40
2020 Q1	$46.5M	Buy	610,481 +404,295	+196%	+$34.4M	0.62%	48
2019 Q4	$18.3M	Sell	206,186 -164	-0.1%	-$13.6K	0.19%	123
2019 Q3	$15.6M	Sell	206,350 -17,693	-8%	-$1.21M	0.17%	132
2019 Q2	$16.3M	Buy	224,043 +7,090	+3%	+$557K	0.18%	123
2019 Q1	$17.5M	Sell	216,953 -23,853	-10%	-$1.95M	0.2%	112
2018 Q4	$22.2M	Sell	240,806 -2,096	-0.9%	-$184K	0.28%	88
2018 Q3	$23M	Buy	242,902 +2,246	+0.9%	+$213K	0.25%	95
2018 Q2	$22.3M	Buy	240,656 +1,813	+0.8%	+$177K	0.25%	95
2018 Q1	$22.6M	Sell	238,843 -23,321	-9%	-$2.56M	0.25%	96
2017 Q4	$25.4M	Sell	262,164 -5,345	-2%	-$504K	0.27%	93
2017 Q3	$23.8M	Sell	267,509 -9,732	-4%	-$741K	0.27%	97
2017 Q2	$20.1M	Sell	277,241 -14,607	-5%	-$982K	0.24%	111
2017 Q1	$19M	Sell	291,848 -28,275	-9%	-$1.78M	0.23%	109
2016 Q4	$20M	Sell	320,123 -27,552	-8%	-$1.68M	0.25%	108
2016 Q3	$21.9M	Sell	347,675 -69,081	-17%	-$4.47M	0.28%	93
2016 Q2	$25.8M	Sell	416,756 -307,111	-42%	-$18.7M	0.33%	85
2016 Q1	$41.3M	Buy	723,867 +6,883	+1%	+$384K	0.55%	59
2015 Q4	$42.5M	Sell	716,984 -8,942	-1%	-$515K	0.57%	54
2015 Q3	$39.5M	Buy	725,926 +25,719	+4%	+$1.67M	0.56%	55
2015 Q2	$47M	Buy	700,207 +26,623	+4%	+$1.74M	0.62%	44
2015 Q1	$39.4M	Buy	673,584 +91,047	+16%	+$5.5M	0.51%	64
2014 Q4	$38.1M	Buy	582,537 +224,848	+63%	+$14.2M	0.49%	59
2014 Q3	$20.7M	Buy	357,689 +44	+0%	+$2.44K	0.26%	108
2014 Q2	$20.2M	Sell	357,645 -570	-0.2%	-$29.9K	0.25%	111
2014 Q1	$18.4M	Sell	358,215 -21,336	-6%	-$1.08M	0.23%	111
2013 Q4	$20M	Sell	379,551 -43,622	-10%	-$2.14M	0.25%	107
2013 Q3	$18.9M	Sell	423,173 -49,537	-10%	-$2.2M	0.25%	105
2013 Q2	$19.5M	Buy	+472,710	New	+$20.7M	0.27%	98

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Regions Financial Corp's ABBV Position: Q1 2026 in Review

Regions Financial Corp increased its AbbVie (ABBV) stake by 3.7% in Q1 2026, buying an estimated $5.88M and bringing the position to 739,038 shares worth $161M. The position accounts for 1.04% of the portfolio, ranked #24.

Regions Financial Corp first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $164M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Regions Financial Corp held 739,038 shares of AbbVie worth $161M as of Q1 2026.
Regions Financial Corp bought 26,524 AbbVie shares in Q1 2026, an estimated $5.88M.
AbbVie made up 1.04% of Regions Financial Corp's portfolio in Q1 2026, its #24 holding.
Regions Financial Corp first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Regions Financial Corp's AbbVie position peaked at $164M in Q3 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Regions Financial Corp's 13F filing for Q1 2026, filed 5 May 2026.